Literature DB >> 22498221

Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.

Guilherme Godoy1, Christian von Bodman, Daher C Chade, Ozdal Dillioglugil, James A Eastham, Samson W Fine, Peter T Scardino, Vincent P Laudone.   

Abstract

PURPOSE: We determined the frequency and distribution of metastases to pelvic lymph nodes in a contemporary American radical prostatectomy series.
MATERIALS AND METHODS: In 642 consecutive patients with clinically localized prostate cancer treated by a single surgeon between 2002 and 2009 pelvic lymph nodes were removed and submitted to the pathologist in separate packets (external iliac, obturator and hypogastric). We assessed the total number of nodes and the number with metastases in each packet.
RESULTS: Complete pathological information was available for 427 patients, who had a median of 16 lymph nodes removed. Of the patients 35 (8.2%) had lymph node metastases, including 1.7% with low, 8.6% with intermediate and 23.9% with high risk cancer. Of those with nodal metastases 24 (69%) had positive lymph nodes in only 1 of the 3 areas, including the external iliac in 4 (11%), the obturator in 9 (26%) and the hypogastric in 11 (31%). Only 37% of the patients had positive nodes only in the external iliac area above the obturator nerve while 60% and 49% had at least 1 positive node in the obturator and the hypogastric area, respectively. Of the patients 80% had only 1 (49%) or 2 (31%) positive nodes.
CONCLUSIONS: In contemporary American patients with clinically localized prostate cancer lymph node metastases were found more often and frequently exclusively in the obturator and hypogastric areas than in the external iliac area. Pelvic lymph node dissection limited to the external iliac area above the obturator nerve would identify and remove lymph node metastases in only a third of the patients with positive nodes found at full pelvic lymph node dissection.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22498221     DOI: 10.1016/j.juro.2012.01.079

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Current status of pelvic lymph node dissection in prostate cancer.

Authors:  Ilija Aleksic; Tyler Luthringer; Vladimir Mouraviev; David M Albala
Journal:  J Robot Surg       Date:  2013-12-11

Review 2.  Sentinel node evaluation in prostate cancer.

Authors:  Ramkishen Narayanan; Timothy G Wilson
Journal:  Clin Exp Metastasis       Date:  2018-09-05       Impact factor: 5.150

3.  Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes.

Authors:  Rodrigo A Ledezma; Edris Negron; Aria A Razmaria; Pankaj Dangle; Scott E Eggener; Arieh L Shalhav; Gregory P Zagaja
Journal:  World J Urol       Date:  2015-02-21       Impact factor: 4.226

4.  Microbiological evaluation of infected pelvic lymphocele after robotic prostatectomy: potential predictors for culture positivity and selection of the best empirical antimicrobial therapy.

Authors:  Alaa Hamada; Catalina Hwang; Jorge Fleisher; Ingolf Tuerk
Journal:  Int Urol Nephrol       Date:  2017-04-24       Impact factor: 2.370

5.  Detection of Lymph Node Metastases with SERRS Nanoparticles.

Authors:  Massimiliano Spaliviero; Stefan Harmsen; Ruimin Huang; Matthew A Wall; Chrysafis Andreou; James A Eastham; Karim A Touijer; Peter T Scardino; Moritz F Kircher
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

6.  Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial.

Authors:  Karim A Touijer; Daniel D Sjoberg; Nicole Benfante; Vincent P Laudone; Behfar Ehdaie; James A Eastham; Peter T Scardino; Andrew Vickers
Journal:  Eur Urol Oncol       Date:  2021-04-15

Review 7.  Extended lymph node dissection in robotic radical prostatectomy: Current status.

Authors:  Sameer Chopra; Mehrdad Alemozaffar; Inderbir Gill; Monish Aron
Journal:  Indian J Urol       Date:  2016 Apr-Jun

8.  Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection.

Authors:  Marco Roscigno; Maria Nicolai; Giovanni La Croce; Federico Pellucchi; Manuela Scarcello; Antonino Saccà; Diego Angiolilli; Daniela Chinaglia; Luigi F Da Pozzo
Journal:  Front Surg       Date:  2018-09-07

Review 9.  Developing a personalized template for lymph node dissection during radical prostatectomy.

Authors:  Ram A Pathak; Ashok K Hemal
Journal:  Transl Androl Urol       Date:  2018-09

Review 10.  Raman Spectroscopy in Prostate Cancer: Techniques, Applications and Advancements.

Authors:  Fortis Gaba; William J Tipping; Mark Salji; Karen Faulds; Duncan Graham; Hing Y Leung
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.